Cited by 390Diabetes Management and ResearchElectrochemical sensors and biosensorsNon-Invasive Vital Sign Monitoring

Clinical evaluation of the GlucoWatch® biographer: a continual, non-invasive glucose monitor for patients with diabetes

Tierney, M.J., Tamada, J.A., Potts, R.O., Jovanovic, L., Garg, S.·2001·Biosensors and Bioelectronics

Abstract

A device providing frequent, automatic, and non-invasive glucose measurements for persons with diabetes has been developed: the GlucoWatch biographer. This device extracts glucose through intact skin via reverse iontophoresis where it is detected by an amperometric biosensor. The biographer can provide glucose readings every 20 min for 12 h. The performance of this device was evaluated in two large clinical studies in a controlled clinical environment (n=231), and the home environment (n=124). Accuracy of the biographer was evaluated by comparing the automatic biographer readings to serial finger-stick blood glucose (BG) measurements. Biographer performance was comparable in both environments. Mean difference between biographer and finger-stick measurements was -0.01 and 0.26 mmol l(-1) for the clinical and home environments, respectively. The mean absolute value of the relative difference was 1.06 and 1.18 mmol l(-1) for the same studies. Correlation coefficient (r) between biographer and finger-stick measurements was 0.85 and 0.80 for the two studies. In both studies, over 94% of the biographer readings were in the clinically acceptable A+B region of the Clarke Error Grid. A slight positive bias is observed for the biographer readings at low BG levels. Biographer accuracy is relatively constant over all rates of BG changes, except when BG decreases more than 10 mmol l(-1) h(-1), which occurred for only 0.2% of points in the home environment study. Biographer precision, as measured by CV%, is approx. 10%. Skin irritation, characterized by erythema and edema, was either non-existent or mild in >90% of subjects and resolved in virtually all subjects without treatment in several days.

Integrity signals

Registry

Crossref · 10.1016/s0956-5663(01)00189-0

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The GlucoWatch Biographer was an FDA-approved device capable of non-invasive glucose monitoring over a 12 hour period with 6 measurements per hour.

    “This US Food and Drug Administration (FDA)-approved device is capable of non-invasive glucose monitoring over a 12 hour period with 6 measurements per hour.”

    From Wearable biosensors for healthcare monitoring (2019) · cites this paper as [30]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Tierney, M. J., Tamada, J. A., Potts, R. O., Jovanovic, L., & Garg, S.
Affiliations
  • Cygnus (United States) (US)
  • Sansum Medical Clinic (US)
  • University of Colorado Health (US)
Corresponding author
Tierney, M.J.
Venue
Biosensors and Bioelectronics
Publisher
Elsevier BV
Published
2001-12
Volume
16
Issue
9-12
Pages
621-629
ISSN
0956-5663 (ISSN-L)
OpenAlex
W2066037251
Cited by
390
References
20
Citations by year
2026: 20 · 2025: 22 · 2024: 19 · 2023: 28 · 2022: 23 · 2021: 21 · 2020: 22 · 2019: 30 · 2018: 24 · 2017: 12 · 2016: 12 · 2015: 9 · 2014: 6 · 2013: 7 · 2012: 7
FWCI
5.77
Type
journal article
Language
en
Open access
closed
Locations
  • Biosensors and Bioelectronics (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Physical Sciences › Engineering › Electrical and Electronic Engineering › Electrochemical sensors and biosensors
  • Physical Sciences › Engineering › Biomedical Engineering › Non-Invasive Vital Sign Monitoring
Keywords
non-invasive glucose monitoring, diabetes mellitus, reverse iontophoresis, amperometric biosensor, Clarke error grid, skin irritation, home monitoring, continuous glucose monitoring
MeSH terms
Diabetes Mellitus, Equipment Design, Glucose, Humans, Iontophoresis, Skin, Blood Glucose Self-Monitoring

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review